Riskpilot← Back to searchSign inGet full accessAlelmo AB
ABActiveOrg 5590906458Åsvägen 53Medical specialists activities · NACE 8622Est. 20161 employees
Revenue 2024
SEK 232K
+425% vs 2023
EBITDA margin
53.0%
+465% vs 2023
Equity ratio
65.9%
Financial strength
Net profit 2024
SEK 110K
+296% vs 2023
| Revenue | SEK 232K | +425% |
| EBITDA | SEK 123K | +465% |
| Net profit | SEK 110K | +296% |
| Total assets | SEK 196K | +804% |
| Equity | SEK 129K | +510% |
| Employees | 1 | — |
Legal name
Alelmo AB
Org number
5590906458
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 december 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva medicinsk konsultation samt handel med konst och antikviteter, handel med värdepapper samt därmed förenlig verksamhet.
Address
Åsvägen 53
Email
ylvakristina@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 110 | 221 | 198 | 44 | 232 |
| Staff expenses | — | — | −23 | −12 | −0 |
| EBITDA | 36 | 70 | 23 | −34 | 123 |
| Depreciation & amort. | −58 | −10 | −55 | −18 | — |
| EBIT | −22 | 60 | −31 | −52 | 123 |
| Net financials | −8 | −2 | 0 | 0 | 1 |
| Profit before tax | −31 | 58 | −31 | −52 | 124 |
| Tax | −0 | −4 | — | −4 | −14 |
| Net profit | −31 | 54 | −31 | −56 | 110 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 246 | 157 | 117 | 22 | 196 |
| Equity | 54 | 108 | 77 | 21 | 129 |
| Long-term debt | 102 | 0 | — | — | — |
| Short-term debt | 90 | 48 | 40 | 1 | 67 |
| Total debt | 192 | 48 | 40 | 1 | 67 |
EBITDA margin
53.0%
This company
15.8%
Market median
+235% vs market
20202024
Equity ratio
65.9%
This company
38.2%
Market median
+73% vs market
20202024
Return on equity
85.2%
This company
18.4%
Market median
+363% vs market
20202024
Net profit margin
47.4%
This company
8.1%
Market median
+485% vs market
20202024
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20202024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
LD | Audit | 2021 – 2022 |
CH Auditor Substitute | Auditor Substitute | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alelmo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Daniel Ragnar Foleby | Audit | 0 companies |
| Carl Håkan Sporrong | Auditor Substitute | 0 companies |
| Anna Märta Oudin | Deputy Board Member | 0 companies |
| Ylva Kristina Oudin | Board of Directors | 0 companies |